These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38326132)

  • 1. Public opinion on global COVID-19 vaccine procurement and distribution policies: A nationally representative survey in Aotearoa New Zealand 2022.
    Kolandai K; Milne B; von Randow M; Bullen C; Marsh S; Crump JA
    Vaccine; 2024 Feb; 42(6):1372-1382. PubMed ID: 38326132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom.
    Vanderslott S; Emary K; Te Water Naude R; English M; Thomas T; Patrick-Smith M; Henry J; Douglas N; Moore M; Stuart A; Hodgson SH; Pollard AJ
    BMJ Glob Health; 2021 Oct; 6(10):. PubMed ID: 34666989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine nationalism is not unethical from a political ethics perspective: Learning from the global COVID-19 vaccine distribution failure.
    Shao Q
    Health Policy; 2024 Mar; 141():104996. PubMed ID: 38266331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pandemics, intellectual property and 'our economy': A worldview analysis of Canada's role in compromising global access to COVID-19 vaccines.
    Brisbois B; Plamondon K; Walugembe D; Pereira RC; Edet C; Dixon J; Habibi R; Karamouzian M; Labonté R; Murthy S; Ravitsky V
    Glob Public Health; 2024 Jan; 19(1):2335360. PubMed ID: 38626321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine nationalism will persist: global public goods need effective engagement of global citizens.
    Peacock SJ
    Global Health; 2022 Feb; 18(1):14. PubMed ID: 35151344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs.
    Farlow A; Torreele E; Gray G; Ruxrungtham K; Rees H; Prasad S; Gomez C; Sall A; Magalhães J; Olliaro P; Terblanche P
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccines.
    Gorodensky A; Kohler JC
    J Pharm Policy Pract; 2022 Aug; 15(1):50. PubMed ID: 35986397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hard choices: Ethical challenges in phase 1 of COVID-19 vaccine roll-out in South Africa.
    Moodley K; Blockman M; Pienaar D; Hawkridge AJ; Meintjes J; Davies MA; London L
    S Afr Med J; 2021 Mar; 111(6):554-558. PubMed ID: 34382565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future.
    Pilkington V; Keestra SM; Hill A
    Front Public Health; 2022; 10():821117. PubMed ID: 35321196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public opinion on global distribution of COVID-19 vaccines: Evidence from two nationally representative surveys in Germany and the United States.
    Klumpp M; Monfared IG; Vollmer S
    Vaccine; 2022 Apr; 40(16):2457-2461. PubMed ID: 35305827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries.
    Aripov T; Wikler D; Asadov D; Tulekov Z; Murzabekova T; Munir KM
    BMC Med Ethics; 2022 Mar; 23(1):21. PubMed ID: 35264173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Persistence of Vaccine Hesitancy: COVID-19 Vaccination Intention in New Zealand.
    Thaker J
    J Health Commun; 2021 Feb; 26(2):104-111. PubMed ID: 33719898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine nationalism: a predicament in ending the COVID-19 pandemic.
    Lagman JDN
    J Public Health (Oxf); 2021 Jun; 43(2):e375-e376. PubMed ID: 33730161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    COVID-19 National Preparedness Collaborators
    Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allocating a COVID-19 Vaccine: Balancing National and International Responsibilities.
    Lie RK; Miller FG
    Milbank Q; 2021 Jun; 99(2):450-466. PubMed ID: 33295679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solidarity across borders: A pragmatic need for global COVID-19 vaccine equity.
    Obinna DN
    Int J Health Plann Manage; 2022 Jan; 37(1):21-29. PubMed ID: 34585430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priorities for global access to life-saving interventions during public health emergencies: Crisis nationalism, solidarity or charity?
    Syntia Munung N; Ujewe SJ; Afolabi MO
    Glob Public Health; 2022; 17(9):1785-1794. PubMed ID: 34555300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pandemic preparedness and response: beyond the Access to COVID-19 Tools Accelerator.
    Saxena A; Baker BK; Banda A; Herlitz A; Miller J; Karrar K; Fleurbaey M; Chiwa E; Atuire CA; Hirose I; Hassoun N
    BMJ Glob Health; 2023 Jan; 8(1):. PubMed ID: 36650015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine nationalism among the public: A cross-country experimental evidence of own-country bias towards COVID-19 vaccination.
    Barceló J; Sheen GC; Tung HH; Wu WC
    Soc Sci Med; 2022 Oct; 310():115278. PubMed ID: 35994879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.